Track the 온코닉테라퓨틱스 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 온코닉테라퓨틱스 has published 30 reports. Market capitalisation: €504.5bn. The latest transaction was reported on 3 July 2026 (Sale). Among the most active insiders: 신종길. The full history is openly available.
30
Insider Decl.
n/a
Thresholds
€205,917
24 ops.
Buy Volume
€8m
4 ops.
Sell Volume
22Σ signal
Buys €205,917€8m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,851 of 29,062 companies
63.0
score / 100
Value
31
Quality
95
FCF yld1.4%
Earn yld2.0%
EV/EBITDA56.7x
ROE29%
Gross mgn100%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Onconic Therapeutics es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de tratamientos innovadores para diversas enfermedades.